An interventional study of Online Gameplay Intervention and Waitlist control in Mild Cognitive Impairment, sponsored by Emory University. Recruiting at 1 site in United States. Open to participants aged 50 Years to 85 Years. Per ClinicalTrials.gov, last updated 2025-12-22.
Sponsored by Emory University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 24 studies in Cognitive Dysfunction by Emory University — 6 open to participants now, 6 under way, none of them phase 3. Cognitive Dysfunction · Emory University.
Among the 24 studies in Cognitive Dysfunction by Emory University, this one is the 3rd largest by planned enrollment of the 19 interventional ones that give a count, is one of 4 that started in 2025, is one of 13 with no phase, and was the 22nd registered.
3,885 studies on the registry are indexed under Cognitive Dysfunction; 1,123 are open to participants now.
Browse Cognitive Dysfunction studies →6 of the 24 studies in Cognitive Dysfunction by Emory University are open now, in 1 country. Recruiting first, the newest first:
Emory University · Sites in United States
Ages 18+ · Healthy volunteers
Emory University · Sites in United States
Ages 50–90
Emory University · Sites in United States
Ages 55+
Emory University · Sites in United States
Ages 50–90
Emory University · Sites in United States
Ages 65+ · Healthy volunteers
By country, each count listing its studies:
Of the 751 Cognitive Dysfunction studies recruiting now, 361 (48%) set no upper age limit and 144 (19%) stop at 75 or younger; 46 take children under 18; 260 take healthy volunteers.
This study: 50 Years to 85 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
24 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 124 is above the median of 64 across 2,804 interventional studies indexed under Cognitive Dysfunction.
Median enrollment 45 across the 19 interventional studies, 234 across the 5 observational. Of the 18 that completed or were terminated, 7 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
Emory University is the lead sponsor of 1,406 studies on the registry; 224 are open to participants now.
Of its 238 completed or terminated interventional studies of FDA-regulated products, 179 (75%) have results posted.
2 of the studies in Cognitive Dysfunction by Emory University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06484244Emory UniversityLocomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease | 2026-12-31 |
| NCT07296133Emory UniversityGAMES Intervention in MCI (Mild Cognitive Impairment) | 2027-03 |
Add all 2 to your calendar (.ics) → With an account.
Among the 24 studies in Cognitive Dysfunction by Emory University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The objective of the present study is to evaluate whether online, remote gameplay can facilitate social engagement and reduce feelings of loneliness and isolation in adults with and without mild cognitive impairment (MCI).
In this study, the investigators will complete a low burden gameplay intervention wherein individuals with and without MCI will be asked to play specially created online versions of common games (such as Connect 4 and Uno) 3 times per week for 12 weeks. Each gameplay session will last at least 15 minutes. Individuals in the intervention condition will begin gameplay immediately, those in the waitlist control condition will complete a 12-week waiting period before beginning gameplay. All games will be delivered via a novel online platform (OneClick; developed by PotLuck, LLC) created specifically to support and enhance social engagement with family members and close friends. In addition to weekly gameplay, participants will receive weekly calls from study staff, both during the waitlist and intervention conditions, to provide support and briefly query about social activities that week. They will also complete a series of questionnaires at 0-, 6-, and 12-weeks of the intervention to evaluate outcomes. The long-term goal of this research is to benefit health and quality-of-life outcomes by delivering remote socialization options to older adults with MCI. OneClick is an easy-to-use platform that has been designed with and for older adults, including those with MCI, to accommodate their unique socialization needs and technology design requirements. The OneClick platform and games used in this study are owned by PotLuck, LLC and therefore stand to be commercialized by their team. Data will not be submitted to the FDA and procedures will not be tested clinically as part of this protocol. In this phase of the study, we will test whether online games delivered via the OneClick platform improve research participants' report of social engagement, isolation, and loneliness alongside other aspects of wellbeing.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Additional Criteria for MCI Group:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive: * brief (\< 10 minutes) psychoeducation about the importance of engaging in social activities to support cognitive stimulation and brain health * technology session to show them how to access games via OneClick * participants will receive weekly calls from study staff to provide support and briefly query about social activities that week. * A subset of questionnaires will be re-administered after 6 weeks of the intervention to capture any change occurring at intervention mid-point. * Following completion of the 12-week intervention, participants will repeat a subset of baseline questionnaires to evaluate for change over time.
Behavioral: Online Gameplay Intervention
Participants will receive: * brief (\< 10 minutes) psychoeducation about the importance of engaging in social activities to support cognitive stimulation and brain health * Participants will be notified that study team will receive weekly phone calls to ask about social activities they completed in the week prior. * Following completion of the 12-week waitlist period, participants will repeat the baseline questionnaires to evaluate for change over time. * After completing the waitlist condition, they will be offered the opportunity to complete the gameplay intervention.
Behavioral: Waitlist control
-The online gameplay intervention includes playing online versions of common games (such as Connect 4 and Uno) with a partner, 3 times per week for at least 15 minutes, for 12 weeks. All games will be delivered via a novel online platform (OneClick; developed by PotLuck, LLC) created specifically to support and enhance social engagement with family members and close friends. * Participants will receive weekly calls from study staff to provide support and briefly query about social activities that week. * They will not receive reminders or be contacted by the study outside of the weekly phone calls, apart from mid intervention questionnaires.
\- Participants will be informed that study team will contact them once per week by telephone for 12 weeks, to ask about social activities they completed in the week prior.
Change in friendship Scale score
The scale consists of 5 core items, each with a 5-point frequency response (Almost always to Not at all). Total possible score range is 5-25. Higher scores indicate greater feelings of social isolation (worse study outcome).
Time frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
Change in UCLA Loneliness Scale score
This is a self -report scale with 20 items. Participants rate each item on a 4-point Likert scale: (1 = Never, 2 = Rarely, 3 = Sometimes, 4 = Often). Total possible score ranges from 20 to 80, with higher scores indicating greater perceived loneliness (worse study outcome).
Time frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
Change in Neuro-QOL score
Neuro-QOL ("Quality of Life in Neurological Disorders") consists of a scale designed to measure health-related quality of life across a variety of neurological conditions. The abbreviated form comprises short forms (8-10 items each) covering 13 key domains: physical, mental, and social health. Response format for each item ranges from "Never" to "Always" or severity levels like "None" to "Cannot do". Scores are summarized and represented with T-scores (mean = 50, SD = 10), derived from their respective calibrated item questionnaire. Higher scores correlate with worse outcome.
Time frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
Change in meaning and purpose score
This scale measures an individual's sense of meaning, purpose, and life satisfaction. Includes 8-9 items in the short form, with statements like "My life has meaning" or "I have a sense of purpose," rated on a 5-point (from 1=never to 5=always). Scores are expressed as T-scores (mean = 50, SD = 10). Higher scores represent better outcome (more positive well-being).
Time frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
Change in Tech Experience and Comfort scale score
Measures confidence in using new or everyday technologies, reflecting both comfort and perceived ability. Includes 10 items, each beginning with the stem "I could use the new technology…". Participant will rate confidence on a 10-point scale (e.g., from "Not at all confident" to "Completely confident"). Total possible score range is 10-100, with better score correlating with greater confidence/comfort in using technology.
Time frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
Change in Perceived Stress score
Measures the degree to which situations in one's life are appraised as stressful. This is a 10-item scale that focuses on feelings of unpredictability, lack of control, and overload during the past month. Response format is with a 5-point Likert scale (0 = Never, 1 = Almost never, 2 = Sometimes, 3 = Fairly often, 4 = Very often). Total score range is 0-40. Higher scores correlate with greater perceived stress (worse outcome).
Time frame: Pre-intervention (Baseline), week 6 and post-intervention (week 12)
Plan to share: Yes — Individual participant data that underlies results reported in as outcomes in publication of RCT results, after being de-identified (includes tables, graphs, appendices, etc.)
Supporting information: Study protocol, Statistical analysis plan
Time frame: Data will be available within 3 months of acceptance for publication and will end 5 years after initial publication.
Access criteria: Data will be shared with researchers who provide a methodologically sound proposal, to achieve aims in approved proposal. Proposals should be directed to kvicker@emory.edu. To gain access, data requestors will need to sign a data access agreement. Data will be made available for 5 years.
No publications or documents are linked to this record.
Started Dec 2025 (actual). Primary completion is estimated for Mar 2027, 15 months after the start.
Of 1,453 non-industry interventional studies with no phase under Cognitive Dysfunction, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 51. This study's planned 15 months is below that.
Counting every sponsor, half of 1,522 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.